No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs1883361 |
chr6:167161571-167161572 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs534700370 |
chr6:167161599-167161600 |
Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs11757986 |
chr6:167161626-167161627 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs553540718 |
chr6:167161632-167161633 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs568542282 |
chr6:167161671-167161672 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs536470407 |
chr6:167161702-167161703 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs375702819 |
chr6:167161721-167161722 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs11758967 |
chr6:167161726-167161727 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs537303738 |
chr6:167161738-167161739 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs11966338 |
chr6:167161761-167161762 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs576813456 |
chr6:167161762-167161763 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs540607928 |
chr6:167161773-167161774 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs559044342 |
chr6:167161785-167161786 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs569154465 |
chr6:167161806-167161807 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs542028976 |
chr6:167161829-167161830 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs563859361 |
chr6:167161852-167161853 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs540218239 |
chr6:167161865-167161866 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs183346078 |
chr6:167161866-167161867 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs552875503 |
chr6:167161887-167161888 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs116402423 |
chr6:167161893-167161894 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs537042365 |
chr6:167161941-167161942 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs11966361 |
chr6:167161943-167161944 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs568581777 |
chr6:167161954-167161955 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs78272821 |
chr6:167161955-167161956 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs548084256 |
chr6:167161956-167161957 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs569877936 |
chr6:167161980-167161981 |
Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs59166746 |
chr6:167162008-167162009 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs536842775 |
chr6:167162010-167162011 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs558847289 |
chr6:167162011-167162012 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs199984820 |
chr6:167162020-167162021 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs377455304 |
chr6:167162041-167162042 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs534332785 |
chr6:167162046-167162047 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs184670240 |
chr6:167162047-167162048 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs186278211 |
chr6:167162048-167162049 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs200924038 |
chr6:167162054-167162055 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs541573956 |
chr6:167162056-167162057 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs563230098 |
chr6:167162057-167162058 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs71553130 |
chr6:167162063-167162064 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs190458916 |
chr6:167162070-167162071 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs183046368 |
chr6:167162072-167162073 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs188132287 |
chr6:167162079-167162080 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs192398982 |
chr6:167162080-167162081 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs182957066 |
chr6:167162096-167162097 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs187546217 |
chr6:167162111-167162112 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs192660589 |
chr6:167162118-167162119 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs184685150 |
chr6:167162133-167162134 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs181648586 |
chr6:167162140-167162141 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs571091577 |
chr6:167162143-167162144 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs367597499 |
chr6:167162159-167162160 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs556865155 |
chr6:167162162-167162163 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|